Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Massol

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Therapie|June 14, 2014
Better defining target populations for drugs with a view to reimbursementJacques Massol, Jean-Pierre Boissel
Presse Medicale (Paris, France : 1983)|February 3, 2007
[Evaluation of drug efficacy]Jacques Massol, Claire Le Jeunne
Therapie|January 22, 2008
How to anticipate the assessment of the public health benefit of new medicines?Jacques Massol, Alain Puech, Jean-Pierre Boissel, et al.
Therapie|July 10, 2016
[Not Available]Thierry Moreau Defarges, Michel Guerbet, Jacques Massol, et al.
Therapie|July 10, 2016
[Not Available]Jacques Massol, Alain Puech, Jean-Pierre Boissel, et al.
Therapie|March 14, 2007
Use of the foreign studies: transposition of the results, prediction of the therapeutic effects in the french population, modelling of the public health interestJacques Massol, Myriam Zylberman, Jean-Marie Goehrs, et al.
Therapie|August 20, 2011
Impact of drugs on the environment: state of play, risks, evaluation, communicationThierry Moreau Defarges, Michel Guerbet, Jacques Massol, et al.
Therapie|January 22, 2008
[How should one anticipate the assessment of the public health benefit of new medicines?]Jacques Massol, Alain Puech, Jean-Pierre Boissel, et al.
Therapie|September 22, 2010
How to best define target populations of medicines in view of their coverage by the national health insurance scheme?Françoise F Hamers, Jacques Massol, Patricia Maillère, et al.
Therapie|July 10, 2016
Use of the Foreign Studies: Transposition of the Results, Prediction of the Therapeutic Effects in the French Population, Modelling of the Public Health InterestJacques Massol, Myriam Zylberman, Jean-Marie Goehrs, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Therapie|June 14, 2014
Better defining target populations for drugs with a view to reimbursementJacques Massol, Jean-Pierre Boissel
Presse Medicale (Paris, France : 1983)|February 3, 2007
[Evaluation of drug efficacy]Jacques Massol, Claire Le Jeunne
Therapie|January 22, 2008
How to anticipate the assessment of the public health benefit of new medicines?Jacques Massol, Alain Puech, Jean-Pierre Boissel, et al.
Therapie|July 10, 2016
[Not Available]Thierry Moreau Defarges, Michel Guerbet, Jacques Massol, et al.
Therapie|July 10, 2016
[Not Available]Jacques Massol, Alain Puech, Jean-Pierre Boissel, et al.
Therapie|March 14, 2007
Use of the foreign studies: transposition of the results, prediction of the therapeutic effects in the french population, modelling of the public health interestJacques Massol, Myriam Zylberman, Jean-Marie Goehrs, et al.
Therapie|August 20, 2011
Impact of drugs on the environment: state of play, risks, evaluation, communicationThierry Moreau Defarges, Michel Guerbet, Jacques Massol, et al.
Therapie|January 22, 2008
[How should one anticipate the assessment of the public health benefit of new medicines?]Jacques Massol, Alain Puech, Jean-Pierre Boissel, et al.
Therapie|September 22, 2010
How to best define target populations of medicines in view of their coverage by the national health insurance scheme?Françoise F Hamers, Jacques Massol, Patricia Maillère, et al.
Therapie|July 10, 2016
Use of the Foreign Studies: Transposition of the Results, Prediction of the Therapeutic Effects in the French Population, Modelling of the Public Health InterestJacques Massol, Myriam Zylberman, Jean-Marie Goehrs, et al.
Pageof 5